Literature DB >> 34393335

Biliary Strictures: Etiologies and Medical Management.

Terrance Rodrigues1, Justin R Boike1.   

Abstract

Biliary strictures have several etiologies that can broadly be classified into benign and malignant causes. The clinical presentation is variable with strictures identified incidentally on imaging or during the evaluation of routine laboratory abnormalities. Symptoms and cholangitis lead to imaging that can diagnose biliary strictures. The diagnosis and medical management of biliary strictures will be discussed in this article. Thieme. All rights reserved.

Entities:  

Keywords:  biliary strictures; hyperbilirubinemia; medical management

Year:  2021        PMID： 34393335      PMCID： PMC8354727          DOI： 10.1055/s-0041-1731086

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN： 0739-9529            Impact factor:   1.780


  83 in total

Review 1.  Benign biliary strictures: a current comprehensive clinical and imaging review.

Authors:  Alampady Krishna Prasad Shanbhogue; Sree Harsha Tirumani; Srinivasa R Prasad; Najla Fasih; Matthew McInnes
Journal:  AJR Am J Roentgenol       Date:  2011-08       Impact factor: 3.959

Review 2.  Malignant biliary obstruction: From palliation to treatment.

Authors:  Brian R Boulay; Aleksandr Birg
Journal:  World J Gastrointest Oncol       Date:  2016-06-15

3.  Recurrent pyogenic cholangitis: comparison between MR cholangiography and direct cholangiography.

Authors:  M S Park; J S Yu; K W Kim; M J Kim; J P Chung; S W Yoon; J J Chung; J T Lee; H S Yoo
Journal:  Radiology       Date:  2001-09       Impact factor: 11.105

4.  Clinical Features, Response to Treatment, and Outcomes of IgG4-Related Sclerosing Cholangitis.

Authors:  Atsushi Tanaka; Susumu Tazuma; Kazuichi Okazaki; Takahiro Nakazawa; Kazuo Inui; Tsutomu Chiba; Hajime Takikawa
Journal:  Clin Gastroenterol Hepatol       Date:  2017-01-20       Impact factor: 11.382

5.  Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study.

Authors:  J H Tabibian; E Weeding; R A Jorgensen; J L Petz; J C Keach; J A Talwalkar; K D Lindor
Journal:  Aliment Pharmacol Ther       Date:  2013-02-05       Impact factor: 8.171

6.  Cholangiocarcinoma complicating primary sclerosing cholangitis.

Authors:  C B Rosen; D M Nagorney; R H Wiesner; R J Coffey; N F LaRusso
Journal:  Ann Surg       Date:  1991-01       Impact factor: 12.969

7.  Patients with obstructive jaundice and biliary stricture ± mass lesion on imaging: prevalence of malignancy and potential role of EUS-FNA.

Authors:  Pavan Tummala; Satish Munigala; Mohamad A Eloubeidi; Banke Agarwal
Journal:  J Clin Gastroenterol       Date:  2013-07       Impact factor: 3.062

8.  Diagnosis and prognosis of AIDS-related cholangitis.

Authors:  M Ducreux; C Buffet; P Lamy; L Beaugerie; J Fritsch; A Choury; C Liguory; P Longuet; J P Gendre; F Vachon
Journal:  AIDS       Date:  1995-08       Impact factor: 4.177

9.  Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.

Authors:  Amaar Ghazale; Suresh T Chari; Lizhi Zhang; Thomas C Smyrk; Naoki Takahashi; Michael J Levy; Mark D Topazian; Jonathan E Clain; Randall K Pearson; Bret T Petersen; Santhi Swaroop Vege; Keith Lindor; Michael B Farnell
Journal:  Gastroenterology       Date:  2007-12-07       Impact factor: 22.682

10.  High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.

Authors:  Keith D Lindor; Kris V Kowdley; Velimir A C Luketic; M Edwyn Harrison; Timothy McCashland; Alex S Befeler; Denise Harnois; Roberta Jorgensen; Jan Petz; Jill Keach; Jody Mooney; Carol Sargeant; Julie Braaten; Tamara Bernard; Debra King; Ellen Miceli; Jeff Schmoll; Tanya Hoskin; Prabin Thapa; Felicity Enders
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.